According to authorities in China, a drug used in Japan to treat new strains of influenza has appeared to be effective in coronavirus patients.
An official at China’s science and technology ministry, said favipiravir, developed by a subsidiary of Fujifilm, had produced encouraging outcomes in clinical trials in Wuhan and Shenzhen involving 340 patients.
Patients who were given the medicine turned negative for the virus after an average of four days after becoming positive, compared with an average of 11 days for those who were not treated with the drug.
In addition, X-rays confirmed improvements in lung condition in about 91% of the patients who were treated with favipiravir, compared to 62% or those without the drug.
The massive wildfire in the Aude’s Corbières massif, has now been fully extinguished after three weeks. ...
Read More
It’s been reported that Uber plans to launch high-speed trains between London, Paris, Lille, and Brussels by 2029, partnering with Gemini Trains. ...
Read More
Éric Ciotti has officially announced his candidacy for mayor of Nice in the March 2026 municipal elections, challenging current mayor Christian Estros...
Read More
As 12 million students return to class in France on the 1st of September, several key changes are being introduced. These include mandatory sex educat...
Read More
A stormy and rainy episode is expected tomorrow in the Alpes-Maritimes and Var, with heavy rainfall possibly reaching 100mm along the coast....
Read More
